JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2122231, encodeId=599c212223140, content=偏重的研究方向：动物肿瘤;病毒溶瘤机制 经验分享：目前还没有reviewer接收… 18 Reviewer(s) invited 03 Mar 23 Submission under peer review 22 Feb 2023 Submission passed technical check 22 Feb 2023 Submission is under technical check 21 Feb 2023 Submission received 21 Feb 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30da6430732, createdName=ms1000002058558009, createdTime=Tue Mar 28 10:27:01 CST 2023, time=2023-03-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2107011, encodeId=75a9210e011a5, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：11.16 submissions. 11.17 Technical check in progress 11.17 ready to be assigned to an editor 11.18 assigned editor 11.24 10 reviewers invited/ two reviewers accepted 11.25 one reviewer report received 12.06 request revise 12.17 revise resubmit 12.19 editor evaluating revision 12.21 accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Thu Dec 22 01:03:56 CST 2022, time=2022-12-22, status=1, ipAttribution=福冈县), GetPortalCommentsPageByObjectIdResponse(id=2166173, encodeId=7c5321661e3ba, content=偏重的研究方向：肿瘤 经验分享：这杂志浪费时间，两个审稿人，一个小修，一个要求加实验，审了三个月，编辑直接给无理由拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bfa2375214, createdName=12300121m89暂无昵称, createdTime=Wed Nov 01 19:58:53 CST 2023, time=2023-11-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2155055, encodeId=5c002155055cb, content=有没有前辈给指导一下投了一个月了还是Peer review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/26/33b0c3de498c5daa6dec753e81adcdf4.jpg, createdBy=9bdb2519180, createdName=橘子月, createdTime=Mon Aug 28 23:35:39 CST 2023, time=2023-08-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2120358, encodeId=97b6212035869, content=偏重的研究方向：肿瘤 经验分享：记录一下自己的下投稿经历，希望文章接受 2023-3-18 submitted 2023-3-18 14 reviewers invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Sat Mar 18 23:29:22 CST 2023, time=2023-03-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2145621, encodeId=89262145621c2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信 经验分享：肿瘤生信加了qPCR Submission status Date 29 Jun 2023 Submission accepted 29 Jun 2023 Submission under peer review 24 May 2023 Submission passed technical check 24 May 2023 Submission is under technical check 23 May 2023 Submission received 23 May 2023 一个月直接接收没有返修...现在还是懵的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acc08219218, createdName=ms6000000533964556, createdTime=Fri Jun 30 09:58:44 CST 2023, time=2023-06-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154696, encodeId=82242154696a6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：生信+WB验证;肿瘤 经验分享：记录一下，今天距离我投稿刚满一个月，目前状态依然是正在邀请5个审稿人，求求了，审稿人们接受审稿吧~等着毕业咧，等不起哇~（接评论区大神们的accept，接心软审稿人~~~）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884e8240952, createdName=ms7000001703629541, createdTime=Sat Aug 26 17:10:22 CST 2023, time=2023-08-26, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2157497, encodeId=b88f215e49787, content=审了一个月了今天突然变成editor appointed，有没有同学知道这是什么情况啊😳, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59538612446, createdName=ms3000001466183845, createdTime=Wed Sep 13 10:58:27 CST 2023, time=2023-09-13, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志，去年5月投了篇临床预测模型seer数据库文章，大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2182701, encodeId=5bfd2182e01db, content=偏重的研究方向：肿瘤 经验分享：记录：生信加验证 23.12.12投稿 24.1.17返两个审稿人意见，都是小修，加起来6条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc7c5397146, createdName=ms3000000321226977, createdTime=Fri Jan 19 20:28:23 CST 2024, time=2024-01-19, status=1, ipAttribution=)]

2023-03-28 ms1000002058558009 来自北京

偏重的研究方向：动物肿瘤;病毒溶瘤机制
经验分享：目前还没有reviewer接收…
18 Reviewer(s) invited 03 Mar 23
Submission under peer review
22 Feb 2023
Submission passed technical check
22 Feb 2023
Submission is under technical check
21 Feb 2023
Submission received
21 Feb 2023

36 22

展开22条回复

[GetPortalCommentsPageByObjectIdResponse(id=2122231, encodeId=599c212223140, content=偏重的研究方向：动物肿瘤;病毒溶瘤机制 经验分享：目前还没有reviewer接收… 18 Reviewer(s) invited 03 Mar 23 Submission under peer review 22 Feb 2023 Submission passed technical check 22 Feb 2023 Submission is under technical check 21 Feb 2023 Submission received 21 Feb 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30da6430732, createdName=ms1000002058558009, createdTime=Tue Mar 28 10:27:01 CST 2023, time=2023-03-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2107011, encodeId=75a9210e011a5, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：11.16 submissions. 11.17 Technical check in progress 11.17 ready to be assigned to an editor 11.18 assigned editor 11.24 10 reviewers invited/ two reviewers accepted 11.25 one reviewer report received 12.06 request revise 12.17 revise resubmit 12.19 editor evaluating revision 12.21 accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Thu Dec 22 01:03:56 CST 2022, time=2022-12-22, status=1, ipAttribution=福冈县), GetPortalCommentsPageByObjectIdResponse(id=2166173, encodeId=7c5321661e3ba, content=偏重的研究方向：肿瘤 经验分享：这杂志浪费时间，两个审稿人，一个小修，一个要求加实验，审了三个月，编辑直接给无理由拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bfa2375214, createdName=12300121m89暂无昵称, createdTime=Wed Nov 01 19:58:53 CST 2023, time=2023-11-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2155055, encodeId=5c002155055cb, content=有没有前辈给指导一下投了一个月了还是Peer review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/26/33b0c3de498c5daa6dec753e81adcdf4.jpg, createdBy=9bdb2519180, createdName=橘子月, createdTime=Mon Aug 28 23:35:39 CST 2023, time=2023-08-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2120358, encodeId=97b6212035869, content=偏重的研究方向：肿瘤 经验分享：记录一下自己的下投稿经历，希望文章接受 2023-3-18 submitted 2023-3-18 14 reviewers invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Sat Mar 18 23:29:22 CST 2023, time=2023-03-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2145621, encodeId=89262145621c2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信 经验分享：肿瘤生信加了qPCR Submission status Date 29 Jun 2023 Submission accepted 29 Jun 2023 Submission under peer review 24 May 2023 Submission passed technical check 24 May 2023 Submission is under technical check 23 May 2023 Submission received 23 May 2023 一个月直接接收没有返修...现在还是懵的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acc08219218, createdName=ms6000000533964556, createdTime=Fri Jun 30 09:58:44 CST 2023, time=2023-06-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154696, encodeId=82242154696a6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：生信+WB验证;肿瘤 经验分享：记录一下，今天距离我投稿刚满一个月，目前状态依然是正在邀请5个审稿人，求求了，审稿人们接受审稿吧~等着毕业咧，等不起哇~（接评论区大神们的accept，接心软审稿人~~~）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884e8240952, createdName=ms7000001703629541, createdTime=Sat Aug 26 17:10:22 CST 2023, time=2023-08-26, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2157497, encodeId=b88f215e49787, content=审了一个月了今天突然变成editor appointed，有没有同学知道这是什么情况啊😳, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59538612446, createdName=ms3000001466183845, createdTime=Wed Sep 13 10:58:27 CST 2023, time=2023-09-13, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志，去年5月投了篇临床预测模型seer数据库文章，大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2182701, encodeId=5bfd2182e01db, content=偏重的研究方向：肿瘤 经验分享：记录：生信加验证 23.12.12投稿 24.1.17返两个审稿人意见，都是小修，加起来6条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc7c5397146, createdName=ms3000000321226977, createdTime=Fri Jan 19 20:28:23 CST 2024, time=2024-01-19, status=1, ipAttribution=)]

2022-12-22 ms7000002055690251 来自福冈县

审稿速度:2.0 | 投稿命中率:50.0
经验分享：11.16 submissions. 11.17 Technical check in progress 11.17 ready to be assigned to an editor 11.18 assigned editor 11.24 10 reviewers invited/ two reviewers accepted 11.25 one reviewer report received 12.06 request revise 12.17 revise resubmit 12.19 editor evaluating revision 12.21 accepted

54 21

展开21条回复

[GetPortalCommentsPageByObjectIdResponse(id=2122231, encodeId=599c212223140, content=偏重的研究方向：动物肿瘤;病毒溶瘤机制 经验分享：目前还没有reviewer接收… 18 Reviewer(s) invited 03 Mar 23 Submission under peer review 22 Feb 2023 Submission passed technical check 22 Feb 2023 Submission is under technical check 21 Feb 2023 Submission received 21 Feb 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30da6430732, createdName=ms1000002058558009, createdTime=Tue Mar 28 10:27:01 CST 2023, time=2023-03-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2107011, encodeId=75a9210e011a5, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：11.16 submissions. 11.17 Technical check in progress 11.17 ready to be assigned to an editor 11.18 assigned editor 11.24 10 reviewers invited/ two reviewers accepted 11.25 one reviewer report received 12.06 request revise 12.17 revise resubmit 12.19 editor evaluating revision 12.21 accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Thu Dec 22 01:03:56 CST 2022, time=2022-12-22, status=1, ipAttribution=福冈县), GetPortalCommentsPageByObjectIdResponse(id=2166173, encodeId=7c5321661e3ba, content=偏重的研究方向：肿瘤 经验分享：这杂志浪费时间，两个审稿人，一个小修，一个要求加实验，审了三个月，编辑直接给无理由拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bfa2375214, createdName=12300121m89暂无昵称, createdTime=Wed Nov 01 19:58:53 CST 2023, time=2023-11-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2155055, encodeId=5c002155055cb, content=有没有前辈给指导一下投了一个月了还是Peer review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/26/33b0c3de498c5daa6dec753e81adcdf4.jpg, createdBy=9bdb2519180, createdName=橘子月, createdTime=Mon Aug 28 23:35:39 CST 2023, time=2023-08-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2120358, encodeId=97b6212035869, content=偏重的研究方向：肿瘤 经验分享：记录一下自己的下投稿经历，希望文章接受 2023-3-18 submitted 2023-3-18 14 reviewers invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Sat Mar 18 23:29:22 CST 2023, time=2023-03-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2145621, encodeId=89262145621c2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信 经验分享：肿瘤生信加了qPCR Submission status Date 29 Jun 2023 Submission accepted 29 Jun 2023 Submission under peer review 24 May 2023 Submission passed technical check 24 May 2023 Submission is under technical check 23 May 2023 Submission received 23 May 2023 一个月直接接收没有返修...现在还是懵的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acc08219218, createdName=ms6000000533964556, createdTime=Fri Jun 30 09:58:44 CST 2023, time=2023-06-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154696, encodeId=82242154696a6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：生信+WB验证;肿瘤 经验分享：记录一下，今天距离我投稿刚满一个月，目前状态依然是正在邀请5个审稿人，求求了，审稿人们接受审稿吧~等着毕业咧，等不起哇~（接评论区大神们的accept，接心软审稿人~~~）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884e8240952, createdName=ms7000001703629541, createdTime=Sat Aug 26 17:10:22 CST 2023, time=2023-08-26, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2157497, encodeId=b88f215e49787, content=审了一个月了今天突然变成editor appointed，有没有同学知道这是什么情况啊😳, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59538612446, createdName=ms3000001466183845, createdTime=Wed Sep 13 10:58:27 CST 2023, time=2023-09-13, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志，去年5月投了篇临床预测模型seer数据库文章，大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2182701, encodeId=5bfd2182e01db, content=偏重的研究方向：肿瘤 经验分享：记录：生信加验证 23.12.12投稿 24.1.17返两个审稿人意见，都是小修，加起来6条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc7c5397146, createdName=ms3000000321226977, createdTime=Fri Jan 19 20:28:23 CST 2024, time=2024-01-19, status=1, ipAttribution=)]

2023-11-01 12300121m89暂无昵称来自广东省

偏重的研究方向：肿瘤
经验分享：这杂志浪费时间，两个审稿人，一个小修，一个要求加实验，审了三个月，编辑直接给无理由拒稿。。。

20 20

展开20条回复

[GetPortalCommentsPageByObjectIdResponse(id=2122231, encodeId=599c212223140, content=偏重的研究方向：动物肿瘤;病毒溶瘤机制 经验分享：目前还没有reviewer接收… 18 Reviewer(s) invited 03 Mar 23 Submission under peer review 22 Feb 2023 Submission passed technical check 22 Feb 2023 Submission is under technical check 21 Feb 2023 Submission received 21 Feb 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30da6430732, createdName=ms1000002058558009, createdTime=Tue Mar 28 10:27:01 CST 2023, time=2023-03-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2107011, encodeId=75a9210e011a5, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：11.16 submissions. 11.17 Technical check in progress 11.17 ready to be assigned to an editor 11.18 assigned editor 11.24 10 reviewers invited/ two reviewers accepted 11.25 one reviewer report received 12.06 request revise 12.17 revise resubmit 12.19 editor evaluating revision 12.21 accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Thu Dec 22 01:03:56 CST 2022, time=2022-12-22, status=1, ipAttribution=福冈县), GetPortalCommentsPageByObjectIdResponse(id=2166173, encodeId=7c5321661e3ba, content=偏重的研究方向：肿瘤 经验分享：这杂志浪费时间，两个审稿人，一个小修，一个要求加实验，审了三个月，编辑直接给无理由拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bfa2375214, createdName=12300121m89暂无昵称, createdTime=Wed Nov 01 19:58:53 CST 2023, time=2023-11-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2155055, encodeId=5c002155055cb, content=有没有前辈给指导一下投了一个月了还是Peer review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/26/33b0c3de498c5daa6dec753e81adcdf4.jpg, createdBy=9bdb2519180, createdName=橘子月, createdTime=Mon Aug 28 23:35:39 CST 2023, time=2023-08-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2120358, encodeId=97b6212035869, content=偏重的研究方向：肿瘤 经验分享：记录一下自己的下投稿经历，希望文章接受 2023-3-18 submitted 2023-3-18 14 reviewers invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Sat Mar 18 23:29:22 CST 2023, time=2023-03-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2145621, encodeId=89262145621c2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信 经验分享：肿瘤生信加了qPCR Submission status Date 29 Jun 2023 Submission accepted 29 Jun 2023 Submission under peer review 24 May 2023 Submission passed technical check 24 May 2023 Submission is under technical check 23 May 2023 Submission received 23 May 2023 一个月直接接收没有返修...现在还是懵的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acc08219218, createdName=ms6000000533964556, createdTime=Fri Jun 30 09:58:44 CST 2023, time=2023-06-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154696, encodeId=82242154696a6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：生信+WB验证;肿瘤 经验分享：记录一下，今天距离我投稿刚满一个月，目前状态依然是正在邀请5个审稿人，求求了，审稿人们接受审稿吧~等着毕业咧，等不起哇~（接评论区大神们的accept，接心软审稿人~~~）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884e8240952, createdName=ms7000001703629541, createdTime=Sat Aug 26 17:10:22 CST 2023, time=2023-08-26, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2157497, encodeId=b88f215e49787, content=审了一个月了今天突然变成editor appointed，有没有同学知道这是什么情况啊😳, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59538612446, createdName=ms3000001466183845, createdTime=Wed Sep 13 10:58:27 CST 2023, time=2023-09-13, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志，去年5月投了篇临床预测模型seer数据库文章，大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2182701, encodeId=5bfd2182e01db, content=偏重的研究方向：肿瘤 经验分享：记录：生信加验证 23.12.12投稿 24.1.17返两个审稿人意见，都是小修，加起来6条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc7c5397146, createdName=ms3000000321226977, createdTime=Fri Jan 19 20:28:23 CST 2024, time=2024-01-19, status=1, ipAttribution=)]

2023-08-28 橘子月来自山东省

有没有前辈给指导一下投了一个月了还是Peer review

30 20

展开20条回复

[GetPortalCommentsPageByObjectIdResponse(id=2122231, encodeId=599c212223140, content=偏重的研究方向：动物肿瘤;病毒溶瘤机制 经验分享：目前还没有reviewer接收… 18 Reviewer(s) invited 03 Mar 23 Submission under peer review 22 Feb 2023 Submission passed technical check 22 Feb 2023 Submission is under technical check 21 Feb 2023 Submission received 21 Feb 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30da6430732, createdName=ms1000002058558009, createdTime=Tue Mar 28 10:27:01 CST 2023, time=2023-03-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2107011, encodeId=75a9210e011a5, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：11.16 submissions. 11.17 Technical check in progress 11.17 ready to be assigned to an editor 11.18 assigned editor 11.24 10 reviewers invited/ two reviewers accepted 11.25 one reviewer report received 12.06 request revise 12.17 revise resubmit 12.19 editor evaluating revision 12.21 accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Thu Dec 22 01:03:56 CST 2022, time=2022-12-22, status=1, ipAttribution=福冈县), GetPortalCommentsPageByObjectIdResponse(id=2166173, encodeId=7c5321661e3ba, content=偏重的研究方向：肿瘤 经验分享：这杂志浪费时间，两个审稿人，一个小修，一个要求加实验，审了三个月，编辑直接给无理由拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bfa2375214, createdName=12300121m89暂无昵称, createdTime=Wed Nov 01 19:58:53 CST 2023, time=2023-11-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2155055, encodeId=5c002155055cb, content=有没有前辈给指导一下投了一个月了还是Peer review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/26/33b0c3de498c5daa6dec753e81adcdf4.jpg, createdBy=9bdb2519180, createdName=橘子月, createdTime=Mon Aug 28 23:35:39 CST 2023, time=2023-08-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2120358, encodeId=97b6212035869, content=偏重的研究方向：肿瘤 经验分享：记录一下自己的下投稿经历，希望文章接受 2023-3-18 submitted 2023-3-18 14 reviewers invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Sat Mar 18 23:29:22 CST 2023, time=2023-03-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2145621, encodeId=89262145621c2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信 经验分享：肿瘤生信加了qPCR Submission status Date 29 Jun 2023 Submission accepted 29 Jun 2023 Submission under peer review 24 May 2023 Submission passed technical check 24 May 2023 Submission is under technical check 23 May 2023 Submission received 23 May 2023 一个月直接接收没有返修...现在还是懵的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acc08219218, createdName=ms6000000533964556, createdTime=Fri Jun 30 09:58:44 CST 2023, time=2023-06-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154696, encodeId=82242154696a6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：生信+WB验证;肿瘤 经验分享：记录一下，今天距离我投稿刚满一个月，目前状态依然是正在邀请5个审稿人，求求了，审稿人们接受审稿吧~等着毕业咧，等不起哇~（接评论区大神们的accept，接心软审稿人~~~）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884e8240952, createdName=ms7000001703629541, createdTime=Sat Aug 26 17:10:22 CST 2023, time=2023-08-26, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2157497, encodeId=b88f215e49787, content=审了一个月了今天突然变成editor appointed，有没有同学知道这是什么情况啊😳, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59538612446, createdName=ms3000001466183845, createdTime=Wed Sep 13 10:58:27 CST 2023, time=2023-09-13, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志，去年5月投了篇临床预测模型seer数据库文章，大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2182701, encodeId=5bfd2182e01db, content=偏重的研究方向：肿瘤 经验分享：记录：生信加验证 23.12.12投稿 24.1.17返两个审稿人意见，都是小修，加起来6条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc7c5397146, createdName=ms3000000321226977, createdTime=Fri Jan 19 20:28:23 CST 2024, time=2024-01-19, status=1, ipAttribution=)]

2023-03-18 1489114dm38(暂无昵称) 来自四川省

偏重的研究方向：肿瘤
经验分享：记录一下自己的下投稿经历，希望文章接受 2023-3-18 submitted 2023-3-18 14 reviewers invited

47 20

展开20条回复

[GetPortalCommentsPageByObjectIdResponse(id=2122231, encodeId=599c212223140, content=偏重的研究方向：动物肿瘤;病毒溶瘤机制 经验分享：目前还没有reviewer接收… 18 Reviewer(s) invited 03 Mar 23 Submission under peer review 22 Feb 2023 Submission passed technical check 22 Feb 2023 Submission is under technical check 21 Feb 2023 Submission received 21 Feb 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30da6430732, createdName=ms1000002058558009, createdTime=Tue Mar 28 10:27:01 CST 2023, time=2023-03-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2107011, encodeId=75a9210e011a5, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：11.16 submissions. 11.17 Technical check in progress 11.17 ready to be assigned to an editor 11.18 assigned editor 11.24 10 reviewers invited/ two reviewers accepted 11.25 one reviewer report received 12.06 request revise 12.17 revise resubmit 12.19 editor evaluating revision 12.21 accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Thu Dec 22 01:03:56 CST 2022, time=2022-12-22, status=1, ipAttribution=福冈县), GetPortalCommentsPageByObjectIdResponse(id=2166173, encodeId=7c5321661e3ba, content=偏重的研究方向：肿瘤 经验分享：这杂志浪费时间，两个审稿人，一个小修，一个要求加实验，审了三个月，编辑直接给无理由拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bfa2375214, createdName=12300121m89暂无昵称, createdTime=Wed Nov 01 19:58:53 CST 2023, time=2023-11-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2155055, encodeId=5c002155055cb, content=有没有前辈给指导一下投了一个月了还是Peer review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/26/33b0c3de498c5daa6dec753e81adcdf4.jpg, createdBy=9bdb2519180, createdName=橘子月, createdTime=Mon Aug 28 23:35:39 CST 2023, time=2023-08-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2120358, encodeId=97b6212035869, content=偏重的研究方向：肿瘤 经验分享：记录一下自己的下投稿经历，希望文章接受 2023-3-18 submitted 2023-3-18 14 reviewers invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Sat Mar 18 23:29:22 CST 2023, time=2023-03-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2145621, encodeId=89262145621c2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信 经验分享：肿瘤生信加了qPCR Submission status Date 29 Jun 2023 Submission accepted 29 Jun 2023 Submission under peer review 24 May 2023 Submission passed technical check 24 May 2023 Submission is under technical check 23 May 2023 Submission received 23 May 2023 一个月直接接收没有返修...现在还是懵的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acc08219218, createdName=ms6000000533964556, createdTime=Fri Jun 30 09:58:44 CST 2023, time=2023-06-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154696, encodeId=82242154696a6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：生信+WB验证;肿瘤 经验分享：记录一下，今天距离我投稿刚满一个月，目前状态依然是正在邀请5个审稿人，求求了，审稿人们接受审稿吧~等着毕业咧，等不起哇~（接评论区大神们的accept，接心软审稿人~~~）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884e8240952, createdName=ms7000001703629541, createdTime=Sat Aug 26 17:10:22 CST 2023, time=2023-08-26, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2157497, encodeId=b88f215e49787, content=审了一个月了今天突然变成editor appointed，有没有同学知道这是什么情况啊😳, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59538612446, createdName=ms3000001466183845, createdTime=Wed Sep 13 10:58:27 CST 2023, time=2023-09-13, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志，去年5月投了篇临床预测模型seer数据库文章，大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2182701, encodeId=5bfd2182e01db, content=偏重的研究方向：肿瘤 经验分享：记录：生信加验证 23.12.12投稿 24.1.17返两个审稿人意见，都是小修，加起来6条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc7c5397146, createdName=ms3000000321226977, createdTime=Fri Jan 19 20:28:23 CST 2024, time=2024-01-19, status=1, ipAttribution=)]

2023-06-30 ms6000000533964556 来自山东省

审稿速度:1.0 | 投稿命中率:95.0
偏重的研究方向：肿瘤;生信
经验分享：肿瘤生信加了qPCR
Submission status Date
29 Jun 2023

Submission accepted
29 Jun 2023

Submission under peer review
24 May 2023

Submission passed technical check
24 May 2023

Submission is under technical check
23 May 2023

Submission received
23 May 2023

一个月直接接收没有返修...现在还是懵的

47 18

展开18条回复

[GetPortalCommentsPageByObjectIdResponse(id=2122231, encodeId=599c212223140, content=偏重的研究方向：动物肿瘤;病毒溶瘤机制 经验分享：目前还没有reviewer接收… 18 Reviewer(s) invited 03 Mar 23 Submission under peer review 22 Feb 2023 Submission passed technical check 22 Feb 2023 Submission is under technical check 21 Feb 2023 Submission received 21 Feb 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30da6430732, createdName=ms1000002058558009, createdTime=Tue Mar 28 10:27:01 CST 2023, time=2023-03-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2107011, encodeId=75a9210e011a5, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：11.16 submissions. 11.17 Technical check in progress 11.17 ready to be assigned to an editor 11.18 assigned editor 11.24 10 reviewers invited/ two reviewers accepted 11.25 one reviewer report received 12.06 request revise 12.17 revise resubmit 12.19 editor evaluating revision 12.21 accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Thu Dec 22 01:03:56 CST 2022, time=2022-12-22, status=1, ipAttribution=福冈县), GetPortalCommentsPageByObjectIdResponse(id=2166173, encodeId=7c5321661e3ba, content=偏重的研究方向：肿瘤 经验分享：这杂志浪费时间，两个审稿人，一个小修，一个要求加实验，审了三个月，编辑直接给无理由拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bfa2375214, createdName=12300121m89暂无昵称, createdTime=Wed Nov 01 19:58:53 CST 2023, time=2023-11-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2155055, encodeId=5c002155055cb, content=有没有前辈给指导一下投了一个月了还是Peer review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/26/33b0c3de498c5daa6dec753e81adcdf4.jpg, createdBy=9bdb2519180, createdName=橘子月, createdTime=Mon Aug 28 23:35:39 CST 2023, time=2023-08-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2120358, encodeId=97b6212035869, content=偏重的研究方向：肿瘤 经验分享：记录一下自己的下投稿经历，希望文章接受 2023-3-18 submitted 2023-3-18 14 reviewers invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Sat Mar 18 23:29:22 CST 2023, time=2023-03-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2145621, encodeId=89262145621c2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信 经验分享：肿瘤生信加了qPCR Submission status Date 29 Jun 2023 Submission accepted 29 Jun 2023 Submission under peer review 24 May 2023 Submission passed technical check 24 May 2023 Submission is under technical check 23 May 2023 Submission received 23 May 2023 一个月直接接收没有返修...现在还是懵的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acc08219218, createdName=ms6000000533964556, createdTime=Fri Jun 30 09:58:44 CST 2023, time=2023-06-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154696, encodeId=82242154696a6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：生信+WB验证;肿瘤 经验分享：记录一下，今天距离我投稿刚满一个月，目前状态依然是正在邀请5个审稿人，求求了，审稿人们接受审稿吧~等着毕业咧，等不起哇~（接评论区大神们的accept，接心软审稿人~~~）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884e8240952, createdName=ms7000001703629541, createdTime=Sat Aug 26 17:10:22 CST 2023, time=2023-08-26, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2157497, encodeId=b88f215e49787, content=审了一个月了今天突然变成editor appointed，有没有同学知道这是什么情况啊😳, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59538612446, createdName=ms3000001466183845, createdTime=Wed Sep 13 10:58:27 CST 2023, time=2023-09-13, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志，去年5月投了篇临床预测模型seer数据库文章，大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2182701, encodeId=5bfd2182e01db, content=偏重的研究方向：肿瘤 经验分享：记录：生信加验证 23.12.12投稿 24.1.17返两个审稿人意见，都是小修，加起来6条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc7c5397146, createdName=ms3000000321226977, createdTime=Fri Jan 19 20:28:23 CST 2024, time=2024-01-19, status=1, ipAttribution=)]

2023-08-26 ms7000001703629541 来自甘肃省

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：生信+WB验证;肿瘤
经验分享：记录一下，今天距离我投稿刚满一个月，目前状态依然是正在邀请5个审稿人，求求了，审稿人们接受审稿吧~等着毕业咧，等不起哇~（接评论区大神们的accept，接心软审稿人~~~）

42 17

展开17条回复

[GetPortalCommentsPageByObjectIdResponse(id=2122231, encodeId=599c212223140, content=偏重的研究方向：动物肿瘤;病毒溶瘤机制 经验分享：目前还没有reviewer接收… 18 Reviewer(s) invited 03 Mar 23 Submission under peer review 22 Feb 2023 Submission passed technical check 22 Feb 2023 Submission is under technical check 21 Feb 2023 Submission received 21 Feb 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30da6430732, createdName=ms1000002058558009, createdTime=Tue Mar 28 10:27:01 CST 2023, time=2023-03-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2107011, encodeId=75a9210e011a5, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：11.16 submissions. 11.17 Technical check in progress 11.17 ready to be assigned to an editor 11.18 assigned editor 11.24 10 reviewers invited/ two reviewers accepted 11.25 one reviewer report received 12.06 request revise 12.17 revise resubmit 12.19 editor evaluating revision 12.21 accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Thu Dec 22 01:03:56 CST 2022, time=2022-12-22, status=1, ipAttribution=福冈县), GetPortalCommentsPageByObjectIdResponse(id=2166173, encodeId=7c5321661e3ba, content=偏重的研究方向：肿瘤 经验分享：这杂志浪费时间，两个审稿人，一个小修，一个要求加实验，审了三个月，编辑直接给无理由拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bfa2375214, createdName=12300121m89暂无昵称, createdTime=Wed Nov 01 19:58:53 CST 2023, time=2023-11-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2155055, encodeId=5c002155055cb, content=有没有前辈给指导一下投了一个月了还是Peer review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/26/33b0c3de498c5daa6dec753e81adcdf4.jpg, createdBy=9bdb2519180, createdName=橘子月, createdTime=Mon Aug 28 23:35:39 CST 2023, time=2023-08-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2120358, encodeId=97b6212035869, content=偏重的研究方向：肿瘤 经验分享：记录一下自己的下投稿经历，希望文章接受 2023-3-18 submitted 2023-3-18 14 reviewers invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Sat Mar 18 23:29:22 CST 2023, time=2023-03-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2145621, encodeId=89262145621c2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信 经验分享：肿瘤生信加了qPCR Submission status Date 29 Jun 2023 Submission accepted 29 Jun 2023 Submission under peer review 24 May 2023 Submission passed technical check 24 May 2023 Submission is under technical check 23 May 2023 Submission received 23 May 2023 一个月直接接收没有返修...现在还是懵的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acc08219218, createdName=ms6000000533964556, createdTime=Fri Jun 30 09:58:44 CST 2023, time=2023-06-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154696, encodeId=82242154696a6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：生信+WB验证;肿瘤 经验分享：记录一下，今天距离我投稿刚满一个月，目前状态依然是正在邀请5个审稿人，求求了，审稿人们接受审稿吧~等着毕业咧，等不起哇~（接评论区大神们的accept，接心软审稿人~~~）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884e8240952, createdName=ms7000001703629541, createdTime=Sat Aug 26 17:10:22 CST 2023, time=2023-08-26, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2157497, encodeId=b88f215e49787, content=审了一个月了今天突然变成editor appointed，有没有同学知道这是什么情况啊😳, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59538612446, createdName=ms3000001466183845, createdTime=Wed Sep 13 10:58:27 CST 2023, time=2023-09-13, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志，去年5月投了篇临床预测模型seer数据库文章，大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2182701, encodeId=5bfd2182e01db, content=偏重的研究方向：肿瘤 经验分享：记录：生信加验证 23.12.12投稿 24.1.17返两个审稿人意见，都是小修，加起来6条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc7c5397146, createdName=ms3000000321226977, createdTime=Fri Jan 19 20:28:23 CST 2024, time=2024-01-19, status=1, ipAttribution=)]

2023-09-13 ms3000001466183845 来自陕西省

审了一个月了今天突然变成editor appointed，有没有同学知道这是什么情况啊😳

28 17

展开17条回复

[GetPortalCommentsPageByObjectIdResponse(id=2122231, encodeId=599c212223140, content=偏重的研究方向：动物肿瘤;病毒溶瘤机制 经验分享：目前还没有reviewer接收… 18 Reviewer(s) invited 03 Mar 23 Submission under peer review 22 Feb 2023 Submission passed technical check 22 Feb 2023 Submission is under technical check 21 Feb 2023 Submission received 21 Feb 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30da6430732, createdName=ms1000002058558009, createdTime=Tue Mar 28 10:27:01 CST 2023, time=2023-03-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2107011, encodeId=75a9210e011a5, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：11.16 submissions. 11.17 Technical check in progress 11.17 ready to be assigned to an editor 11.18 assigned editor 11.24 10 reviewers invited/ two reviewers accepted 11.25 one reviewer report received 12.06 request revise 12.17 revise resubmit 12.19 editor evaluating revision 12.21 accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Thu Dec 22 01:03:56 CST 2022, time=2022-12-22, status=1, ipAttribution=福冈县), GetPortalCommentsPageByObjectIdResponse(id=2166173, encodeId=7c5321661e3ba, content=偏重的研究方向：肿瘤 经验分享：这杂志浪费时间，两个审稿人，一个小修，一个要求加实验，审了三个月，编辑直接给无理由拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bfa2375214, createdName=12300121m89暂无昵称, createdTime=Wed Nov 01 19:58:53 CST 2023, time=2023-11-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2155055, encodeId=5c002155055cb, content=有没有前辈给指导一下投了一个月了还是Peer review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/26/33b0c3de498c5daa6dec753e81adcdf4.jpg, createdBy=9bdb2519180, createdName=橘子月, createdTime=Mon Aug 28 23:35:39 CST 2023, time=2023-08-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2120358, encodeId=97b6212035869, content=偏重的研究方向：肿瘤 经验分享：记录一下自己的下投稿经历，希望文章接受 2023-3-18 submitted 2023-3-18 14 reviewers invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Sat Mar 18 23:29:22 CST 2023, time=2023-03-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2145621, encodeId=89262145621c2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信 经验分享：肿瘤生信加了qPCR Submission status Date 29 Jun 2023 Submission accepted 29 Jun 2023 Submission under peer review 24 May 2023 Submission passed technical check 24 May 2023 Submission is under technical check 23 May 2023 Submission received 23 May 2023 一个月直接接收没有返修...现在还是懵的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acc08219218, createdName=ms6000000533964556, createdTime=Fri Jun 30 09:58:44 CST 2023, time=2023-06-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154696, encodeId=82242154696a6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：生信+WB验证;肿瘤 经验分享：记录一下，今天距离我投稿刚满一个月，目前状态依然是正在邀请5个审稿人，求求了，审稿人们接受审稿吧~等着毕业咧，等不起哇~（接评论区大神们的accept，接心软审稿人~~~）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884e8240952, createdName=ms7000001703629541, createdTime=Sat Aug 26 17:10:22 CST 2023, time=2023-08-26, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2157497, encodeId=b88f215e49787, content=审了一个月了今天突然变成editor appointed，有没有同学知道这是什么情况啊😳, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59538612446, createdName=ms3000001466183845, createdTime=Wed Sep 13 10:58:27 CST 2023, time=2023-09-13, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志，去年5月投了篇临床预测模型seer数据库文章，大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2182701, encodeId=5bfd2182e01db, content=偏重的研究方向：肿瘤 经验分享：记录：生信加验证 23.12.12投稿 24.1.17返两个审稿人意见，都是小修，加起来6条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc7c5397146, createdName=ms3000000321226977, createdTime=Fri Jan 19 20:28:23 CST 2024, time=2024-01-19, status=1, ipAttribution=)]

2024-03-12 ms6000001537745536 来自四川省

二战这个杂志，去年5月投了篇临床预测模型seer数据库文章，大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed

15 16

展开16条回复

[GetPortalCommentsPageByObjectIdResponse(id=2122231, encodeId=599c212223140, content=偏重的研究方向：动物肿瘤;病毒溶瘤机制 经验分享：目前还没有reviewer接收… 18 Reviewer(s) invited 03 Mar 23 Submission under peer review 22 Feb 2023 Submission passed technical check 22 Feb 2023 Submission is under technical check 21 Feb 2023 Submission received 21 Feb 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30da6430732, createdName=ms1000002058558009, createdTime=Tue Mar 28 10:27:01 CST 2023, time=2023-03-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2107011, encodeId=75a9210e011a5, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：11.16 submissions. 11.17 Technical check in progress 11.17 ready to be assigned to an editor 11.18 assigned editor 11.24 10 reviewers invited/ two reviewers accepted 11.25 one reviewer report received 12.06 request revise 12.17 revise resubmit 12.19 editor evaluating revision 12.21 accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Thu Dec 22 01:03:56 CST 2022, time=2022-12-22, status=1, ipAttribution=福冈县), GetPortalCommentsPageByObjectIdResponse(id=2166173, encodeId=7c5321661e3ba, content=偏重的研究方向：肿瘤 经验分享：这杂志浪费时间，两个审稿人，一个小修，一个要求加实验，审了三个月，编辑直接给无理由拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bfa2375214, createdName=12300121m89暂无昵称, createdTime=Wed Nov 01 19:58:53 CST 2023, time=2023-11-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2155055, encodeId=5c002155055cb, content=有没有前辈给指导一下投了一个月了还是Peer review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/26/33b0c3de498c5daa6dec753e81adcdf4.jpg, createdBy=9bdb2519180, createdName=橘子月, createdTime=Mon Aug 28 23:35:39 CST 2023, time=2023-08-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2120358, encodeId=97b6212035869, content=偏重的研究方向：肿瘤 经验分享：记录一下自己的下投稿经历，希望文章接受 2023-3-18 submitted 2023-3-18 14 reviewers invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Sat Mar 18 23:29:22 CST 2023, time=2023-03-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2145621, encodeId=89262145621c2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信 经验分享：肿瘤生信加了qPCR Submission status Date 29 Jun 2023 Submission accepted 29 Jun 2023 Submission under peer review 24 May 2023 Submission passed technical check 24 May 2023 Submission is under technical check 23 May 2023 Submission received 23 May 2023 一个月直接接收没有返修...现在还是懵的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acc08219218, createdName=ms6000000533964556, createdTime=Fri Jun 30 09:58:44 CST 2023, time=2023-06-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154696, encodeId=82242154696a6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：生信+WB验证;肿瘤 经验分享：记录一下，今天距离我投稿刚满一个月，目前状态依然是正在邀请5个审稿人，求求了，审稿人们接受审稿吧~等着毕业咧，等不起哇~（接评论区大神们的accept，接心软审稿人~~~）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884e8240952, createdName=ms7000001703629541, createdTime=Sat Aug 26 17:10:22 CST 2023, time=2023-08-26, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2157497, encodeId=b88f215e49787, content=审了一个月了今天突然变成editor appointed，有没有同学知道这是什么情况啊😳, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59538612446, createdName=ms3000001466183845, createdTime=Wed Sep 13 10:58:27 CST 2023, time=2023-09-13, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志，去年5月投了篇临床预测模型seer数据库文章，大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2182701, encodeId=5bfd2182e01db, content=偏重的研究方向：肿瘤 经验分享：记录：生信加验证 23.12.12投稿 24.1.17返两个审稿人意见，都是小修，加起来6条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc7c5397146, createdName=ms3000000321226977, createdTime=Fri Jan 19 20:28:23 CST 2024, time=2024-01-19, status=1, ipAttribution=)]

2024-01-19 ms3000000321226977

偏重的研究方向：肿瘤
经验分享：记录：生信加验证 23.12.12投稿 24.1.17返两个审稿人意见，都是小修，加起来6条意见

62 13

展开13条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务